Inscrição na biblioteca: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Publicou 6 edições por ano

ISSN Imprimir: 0743-4863

ISSN On-line: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Mitochondrial-Targeted Drug and DNA Delivery

Volume 20, Edição 1, 2003, 62 pages
DOI: 10.1615/CritRevTherDrugCarrierSyst.v20.i1.10
Get accessGet access

RESUMO

The field of mitochondrial research is currently among the fastest growing disciplines in biomedicine. Approximately 12,000 articles on mitochondria have been published since the beginning of the new millennium. What brings mitochondria into the limelight of the scientific community? Since the end of the 1980s, a series of key discoveries has been made that have rekindled the scientific interest in this long-known cell organelle. It has become increasingly evident that mitochondrial dysfunction contributes to a variety of human disorders, ranging from neurodegenerative and neuromuscular diseases, obesity, and diabetes to ischemia-reperfusion injury and cancer. Moreover, since the middle of the 1990s, mitochondria, the “power houses” of the cell, have also become accepted as the cells’ “arsenal,” reflecting their increasingly acknowledged key role during apoptosis. Based on these recent developments in mitochondrial research, increased pharmacological and pharmaceutical efforts have lead to the emergence of “mitochondrial medicine” as a new field of biomedical research. Targeting of biologically active molecules to mitochondria in living cells will open avenues for manipulating mitochondrial functions, which may result in the selective protection, repair, or eradication of cells. This review gives a comprehensive overview of current strategies of mitochondrial targeting and their possible therapeutic applications.

CITADO POR
  1. Lacerda Silvia H. D., Abraham Bindu, Stringfellow Thomas C., Indig Guilherme L., Photophysical, Photochemical, and Tumor-selectivity Properties of Bromine Derivatives of Rhodamine-123, Photochemistry and Photobiology, 81, 6, 2005. Crossref

  2. Anders M W, Robotham James L, Sheu Shey-Shing, Mitochondria: new drug targets for oxidative stress-induced diseases, Expert Opinion on Drug Metabolism & Toxicology, 2, 1, 2006. Crossref

  3. Cheng Zhen, Subbarayan Murugesan, Chen Xiaoyuan, Gambhir Sanjiv Sam, Synthesis of (4-[18F]fluorophenyl)triphenylphosphonium as a potential imaging agent for mitochondrial dysfunction, Journal of Labelled Compounds and Radiopharmaceuticals, 48, 2, 2005. Crossref

  4. Duncan Ruth, Targeting and Intracellular Delivery of Drugs, in Encyclopedia of Molecular Cell Biology and Molecular Medicine, 2006. Crossref

  5. Weissig Volkmar, Targeted drug delivery to mammalian mitochondria in living cells, Expert Opinion on Drug Delivery, 2, 1, 2005. Crossref

  6. Twaites Beverley R., de las Heras Alarcón Carolina, Cunliffe David, Lavigne Matthieu, Pennadam Sivanand, Smith James R., Górecki Dariusz C., Alexander Cameron, Thermo and pH responsive polymers as gene delivery vectors: effect of polymer architecture on DNA complexation in vitro, Journal of Controlled Release, 97, 3, 2004. Crossref

  7. D'Souza Gerard G.M., Wagle Mayura A, Saxena Vaibhav, Shah Anee, Approaches for targeting mitochondria in cancer therapy, Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1807, 6, 2011. Crossref

  8. Horobin Richard W., Trapp Stefan, Weissig Volkmar, Mitochondriotropics: A review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria, Journal of Controlled Release, 121, 3, 2007. Crossref

  9. D'Souza Gerard G. M., Weissig Volkmar, An Introduction to Subcellular Nanomedicine: Current Trends and Future Developments, in Organelle-Specific Pharmaceutical Nanotechnology, 2010. Crossref

  10. Galati Giuseppe, O'Brien Peter J, Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties, Free Radical Biology and Medicine, 37, 3, 2004. Crossref

  11. Breunig M., Bauer S., Goepferich A., Polymers and nanoparticles: Intelligent tools for intracellular targeting?, European Journal of Pharmaceutics and Biopharmaceutics, 68, 1, 2008. Crossref

  12. Dhanasekaran Anuradha, Kotamraju Srigiridhar, Karunakaran Chandran, Kalivendi Shasi V., Thomas Simmy, Joseph Joy, Kalyanaraman B., Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: Role of mitochondrial superoxide, Free Radical Biology and Medicine, 39, 5, 2005. Crossref

  13. Kamaly Nazila, Xiao Zeyu, Valencia Pedro M., Radovic-Moreno Aleksandar F., Farokhzad Omid C., Targeted polymeric therapeutic nanoparticles: design, development and clinical translation, Chemical Society Reviews, 41, 7, 2012. Crossref

  14. Heller Anne, Brockhoff Gero, Goepferich Achim, Targeting drugs to mitochondria, European Journal of Pharmaceutics and Biopharmaceutics, 82, 1, 2012. Crossref

  15. Visioli Francesco, Lastra Catalina Alarcón De La, Andres-Lacueva Cristina, Aviram Michael, Calhau Conceição, Cassano Alfredo, D’Archivio Massimo, Faria Ana, Favé Gaëlle, Fogliano Vincenzo, Llorach Rafael, Vitaglione Paola, Zoratti Mario, Edeas Marvin, Polyphenols and Human Health: A Prospectus, Critical Reviews in Food Science and Nutrition, 51, 6, 2011. Crossref

  16. Yu Gwang Sig, Han Jin, Ko Kyung Soo, Choi Joon Sig, Cationic oligopeptide-conjugated mitochondria targeting sequence as a novel carrier system for mitochondria, Macromolecular Research, 22, 1, 2014. Crossref

  17. Doss C. George Priya, Debajyoti C., Debottam S., Disruption of Mitochondrial Complexes in Cancer Stem Cells Through Nano-based Drug Delivery: A Promising Mitochondrial Medicine, Cell Biochemistry and Biophysics, 67, 3, 2013. Crossref

  18. Cheng S.M., Pabba S., Torchilin V.P., Fowle W., Kimpfler A., Schubert R., Weissig V., Towards mitochondria-specific delivery of apoptosis-inducing agents: DQAsomal incorporated paclitaxel, Journal of Drug Delivery Science and Technology, 15, 1, 2005. Crossref

  19. D'Souza Gerard GM, Cheng Shing-Ming, Boddapati Sarathi V, Horobin Richard W, Weissig Volkmar, Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel, Journal of Drug Targeting, 16, 7-8, 2008. Crossref

  20. Margaritelis Nikos V., Cobley James N., Paschalis Vassilis, Veskoukis Aristidis S., Theodorou Anastasios A., Kyparos Antonios, Nikolaidis Michalis G., Principles for integrating reactive species into in vivo biological processes: Examples from exercise physiology, Cellular Signalling, 28, 4, 2016. Crossref

  21. Sheu Shey-Shing, Nauduri Dhananjaya, Anders M.W., Targeting antioxidants to mitochondria: A new therapeutic direction, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1762, 2, 2006. Crossref

  22. Boddapati Sarathi V., Tongcharoensirikul Pakamas, Hanson Robert N., D'Souza Gerard G. M., Torchilin Vladimir P., Weissig Volkmar, Mitochondriotropic Liposomes, Journal of Liposome Research, 15, 1-2, 2005. Crossref

  23. D'Souza Gerard GM, Weissig Volkmar, Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet, Expert Opinion on Drug Delivery, 6, 11, 2009. Crossref

  24. Mitochondria as an Emerging Target for the Delivery of Small Therapeutic Molecules, in Bio-Targets and Drug Delivery Approaches, 2016. Crossref

  25. Weissig Volkmar, Boddapati Sarathi V., Cheng Shing-Ming, D’souza Gerard G. M., Liposomes and Liposome-like Vesicles for Drug and DNA Delivery to Mitochondria, Journal of Liposome Research, 16, 3, 2006. Crossref

  26. Weissig Volkmar, Boddapati Sarathi, Cheng Shing-Ming, D’Souza Gerard, Torchilin Vladimir, Phospholipid- and Nonphospholipid-Based Vesicles for Drug and DNA Delivery to Mitochondria in Living Mammalian Cells, in Liposome Technology, Volume II, 2006. Crossref

  27. Foster Christian, Watson Andre, Kaplinsky Joseph, Kamaly Nazila, Improved Targeting of Cancers with Nanotherapeutics, in Cancer Nanotechnology, 1530, 2017. Crossref

  28. Vo Thuy D., Palsson Bernhard O., Building the power house: recent advances in mitochondrial studies through proteomics and systems biology, American Journal of Physiology-Cell Physiology, 292, 1, 2007. Crossref

  29. Li Qiang, Gao Shane, Mitochondrial Dysfunction in Ischemic Stroke, in Translational Research in Stroke, 2017. Crossref

  30. Brookes Paul S., Yoon Yisang, Robotham James L., Anders M. W., Sheu Shey-Shing, Calcium, ATP, and ROS: a mitochondrial love-hate triangle, American Journal of Physiology-Cell Physiology, 287, 4, 2004. Crossref

  31. CHOI EUN MI, JUNG WOON WON, SUH KWANG SIK, Pinacidil protects osteoblastic cells against antimycin A-induced oxidative damage, Molecular Medicine Reports, 11, 1, 2015. Crossref

  32. Barbhuiya Masuk Ahmed, Uddin Arif, Chakraborty Supriyo, A cross-talk on compositional dynamics and codon usage patterns of mitochondrialCYBgene in Echinodermata, Mitochondrial DNA Part A, 30, 2, 2019. Crossref

  33. Agrawal Udita, Sharma Rajeev, Vyas Suresh P., Targeted Drug Delivery to the Mitochondria, in Targeted Drug Delivery : Concepts and Design, 2015. Crossref

  34. Solomon Melani, D’Souza Gerard G. M., Approaches to Achieving Sub-cellular Targeting of Bioactives Using Pharmaceutical Nanocarriers, in Intracellular Delivery, 5, 2011. Crossref

  35. Ferrati Silvia, Streiff Agathe K., Srinivasan Srimeenakshi, Alexander Jenolyn F., Bhargava Nikhil, Peters Andrew M., Song Nelly E., Tasciotti Ennio, Godin Biana, Ferrari Mauro, Serda Rita E., Mass Transport via Cellular Barriers and Endocytosis, in Intracellular Delivery, 5, 2011. Crossref

  36. Fujimoto Chisato, Yamasoba Tatsuya, Mitochondria-Targeted Antioxidants for Treatment of Hearing Loss: A Systematic Review, Antioxidants, 8, 4, 2019. Crossref

  37. Biasutto Lucia, Dong Lan-Feng, Zoratti Mario, Neuzil Jiri, Mitochondrially targeted anti-cancer agents, Mitochondrion, 10, 6, 2010. Crossref

  38. Guzman-Villanueva Diana, Mendiola Mark R., Nguyen Huy X., Yambao Francis, Yu Nusem, Weissig Volkmar, Conjugation of Triphenylphosphonium Cation to Hydrophobic Moieties to Prepare Mitochondria-Targeting Nanocarriers, in Pharmaceutical Nanotechnology, 2000, 2019. Crossref

  39. Arora Arpita, Behl Tapan, Sehgal Aayush, Singh Sukhbir, Sharma Neelam, Mathew Bijo, Bungau Simona, Targeting cellular batteries for the therapy of neurological diseases, Environmental Science and Pollution Research, 28, 31, 2021. Crossref

  40. Yang Pei-Hui, Sun Xuesong, Chiu Jen-Fu, Sun Hongzhe, He Qing-Yu, Transferrin-Mediated Gold Nanoparticle Cellular Uptake, Bioconjugate Chemistry, 16, 3, 2005. Crossref

  41. Weissig Volkmar, Boddapati Sarathi V, Jabr Lara, D’Souza Gerard G, Mitochondria-specific nanotechnology, Nanomedicine, 2, 3, 2007. Crossref

  42. Zhang Xueying, Eliasberg Claire D., Rodeo Scott A., Mitochondrial dysfunction and potential mitochondrial protectant treatments in tendinopathy, Annals of the New York Academy of Sciences, 1490, 1, 2021. Crossref

  43. Kawai Cintia, Ferreira Juliana C., Baptista Mauricio S., Nantes Iseli L., Not Only Oxidation of Cardiolipin Affects the Affinity of Cytochrome c for Lipid Bilayers, The Journal of Physical Chemistry B, 118, 41, 2014. Crossref

  44. Wang Dongxin, Li Yingqi, Tian Zhimei, Cao Ruixia, Yang Binsheng, Transferrin-conjugated nanodiamond as an intracellular transporter of chemotherapeutic drug and targeting therapy for cancer cells, Therapeutic Delivery, 5, 5, 2014. Crossref

  45. Minko Tamara, Khandare Jayant J., Jayant Sreeja, Polymeric Drugs, in Macromolecular Engineering, 2007. Crossref

  46. D’Souza Gerard G. M., Boddapati Sarathi V., Weissig Volkmar, Gene Therapy of the Other Genome: The Challenges of Treating Mitochondrial DNA Defects, Pharmaceutical Research, 24, 2, 2007. Crossref

Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain